Physiol. Genomics Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Genomics 38: 176-185, 2009. First published May 5, 2009; doi:10.1152/physiolgenomics.00035.2009
1094-8341/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow All Versions of this Article:
38/2/176    most recent
00035.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Pautz, A.
Right arrow Articles by Kleinert, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pautz, A.
Right arrow Articles by Kleinert, H.
Received 25 February 2009; accepted in final form 4 May 2009.
Physiological Genomics 38:176-185 (2009)
1094-8341/09 $8.00 © 2009 American Physiological Society

Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects

Andrea Pautz 1, Peter Rauschkolb 1, Nadine Schmidt 1, Julia Art 1, Matthias Oelze 2, Philip Wenzel 2, Ulrich Förstermann 1, Andreas Daiber 2 and Hartmut Kleinert 1

1 Department of Pharmacology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
2 Department of Internal Medicine II - Cardiology and Angiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

Nitroglycerin (NTG) and pentaerithrityl tetranitrate (PETN) are organic nitrates used in the treatment of angina pectoris, myocardial infarction, and congestive heart failure. Recent data show marked differences in the effects of NTG and PETN on the generation of reactive oxygen species. These differences are attributed to different effects of NTG and PETN on the expression of antioxidative proteins like the heme oxygenase-I. To analyze the expressional effects of NTG and PETN in a more comprehensive manner we performed whole genome expression profiling experiments using cardiac total RNA from NTG- or PETN-treated rats and DNA microarrays containing oligonucleotides representing 27,044 rat gene transcripts. The data obtained show that NTG and PETN together significantly modify the expression of >1,600 genes (NTG 532, PETN 1212). However, the expression of only a small group of these genes (68) was modified by both treatments, indicating marked differences in the expressional effects of NTG and PETN. NTG treatment resulted in the enhanced expression of genes that are believed to be markers for cardiotoxic processes. In addition, NTG treatment reduced the expression of genes described to code for cardioprotective proteins. In sharp contrast, PETN treatment enhanced the expression of cardioprotective genes and reduced the expression of genes believed to perform cardiotoxic effects. In conclusion, our data suggest that NTG treatment results in the induction of cardiotoxic gene expression networks leading to an activation of mechanisms that result in pathological changes in cardiomyocytes. In contrast, PETN treatment seems to activate gene expression networks that result in cardioprotective effects.

organic nitrates; DNA microarrays; qRT-PCR; transcription factor analysis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.